UBC Children's Hospital Research Institute
Welcome,         Profile    Billing    Logout  
 2 Trials 
6 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Connolly, Mary
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Recruiting
2
100
Europe, Canada, US, RoW
EPX-100 (clemizole HCl), Placebo
Epygenix, Harmony Biosciences, LLC
Dravet Syndrome
04/26
05/26
RAD-GRIN-201, NCT06392009: Astroscape: a Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients with TSC or FCD Type II

Recruiting
1/2
30
Europe, Canada, RoW
Radiprodil
GRIN Therapeutics, Inc.
Tuberous Sclerosis Complex, Focal Cortical Dysplasia
07/25
07/26
NCT05818943 / 2022-000317-14: Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder

Active, not recruiting
1
24
Europe, Canada, US, RoW
Radiprodil
GRIN Therapeutics, Inc., GRIN Therapeutics, Inc.
GRIN-related Disorders
11/26
11/26
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
Gill, Inderpal
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Recruiting
2
100
Europe, Canada, US, RoW
EPX-100 (clemizole HCl), Placebo
Epygenix, Harmony Biosciences, LLC
Dravet Syndrome
04/26
05/26
Knight, Elia Pestana
ARGUS, NCT04462770 / 2021-003425-30: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Recruiting
2
100
Europe, Canada, US, RoW
EPX-100 (clemizole HCl), Placebo
Epygenix, Harmony Biosciences, LLC
Dravet Syndrome
04/26
05/26

Download Options